Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 5.3% Today

What is Hims & Hers Health Inc.?

HIMS, a health and wellness company traded on the NYSE, experienced a bullish market sentiment today.

Why is Hims & Hers Health Inc. going up?

HIMS stock is up 5.3% on Sep 12, 2024 18:11

• The rise in bullish options activity for HIMS indicates that sophisticated investors are positive about the company's future.
• Growing interest in HIMS options may suggest anticipation of favorable developments or solid financial results in the upcoming period.
• This bullish trend in HIMS could be influenced by internal insights or favorable industry trends that have attracted the interest of major investors.

HIMS Price Chart

HIMS News

Smart Money Is Betting Big In HIMS Options - Hims & Hers Health ( NYSE:HIMS )

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

https://www.benzinga.com/insights/options/24/09/40839960/smart-money-is-betting-big-in-hims-options

Trending Today

Memecoin ($MEME) Crypto Forecast: Up 5.4% Today

NEO ($NEO) Crypto Forecast: Up 5.3% Today

Nervos Network ($CKB) Crypto Forecast: Down 5.3% Today

Aptos ($APT) Crypto Forecast: Up 9.6% Today

Pepe ($PEPE) Crypto Forecast: Up 8.0% Today

Wormhole ($W) Crypto Forecast: Up 5.1% Today

Bittensor ($TAO) Crypto Forecast: Up 12.9% Today

Ethereum ($ETH) Crypto Forecast: Up 5.3% Today

Arbitrum ($ARB) Crypto Forecast: Up 7.2% Today

Floki ($FLOKI) Crypto Forecast: Up 5.7% Today

Hims & Hers Health Inc. Price History

22.07.2024 - HIMS Stock was up 7.4%

• The bullish movement in HIMS stock today can be attributed to a rating upgrade, signaling great value amid unwarranted concerns.
• The high demand for copycat weight loss drugs, amidst supply shortages, has likely contributed to the stock's strong performance.
• Wall Street recognizing the growth potential of Hims & Hers Health as a company might have further fueled investor optimism and contributed to the bullish market movement.

19.07.2024 - HIMS Stock was up 5.1%

• The strong bullish movement in HIMS stock can be attributed to the increasing demand for the company's copycat weight loss drugs amidst supply shortages, outperforming industry giants like Eli Lilly and Novo Nordisk.
• The exclusive story shared by the COO of Hims & Hers Health about her positive experience with the GLP-1 drugs might have boosted investor confidence in the company's products and future prospects.
• The unusual options activity showing a higher percentage of bearish trades could indicate some short-term skepticism in the market, but the overall positive sentiment and growth potential highlighted in recent updates seem to have overshadowed this.
• The discussion around potential impact from Eli Lilly's investments on Hims & Hers Health stock might have caused some volatility, but the overall growth narrative and market demand for the company's products seem to have driven the bullish movement.

12.08.2024 - HIMS Stock was up 5.3%

• The rise in bullish options activity for HIMS indicates that sophisticated investors are positive about the company's future.
• Growing interest in HIMS options may suggest anticipation of favorable developments or solid financial results in the upcoming period.
• This bullish trend in HIMS could be influenced by internal insights or favorable industry trends that have attracted the interest of major investors.

27.07.2024 - HIMS Stock was down 9.2%

• The bearish movement in HIMS stock could be attributed to the overall negative sentiment in the market, as indicated by American Woodmark's downbeat quarterly results and the slight decrease in U.S. stock futures.
• Despite the bearish trend, there is a silver lining with whales showing a bullish stance on Hims & Hers Health through options trading, suggesting potential positive sentiment in the future.
• Analysts foresee a major growth opportunity for HIMS in the booming weight loss market, which could potentially offset the current bearish movement and drive the stock price higher.
• With a recent rating upgrade highlighting Hims & Hers as a great value amid unwarranted concerns, investors might find reassurance in the company's long-term prospects despite the short-term market fluctuations.

27.07.2024 - HIMS Stock was down 7.5%

• HIMS stock declined following Eli Lilly (LLY) implementing a significant price reduction for its weight-loss drug Zepbound, impacting Hims & Hers Health's competitiveness in the weight-loss treatment market.
• The release of a lower-priced version of Zepbound by Eli Lilly raised concerns among investors regarding HIMS's market share and profitability in the face of intensified competition.
• Investor reaction to the news highlighted the potential risk presented by Eli Lilly's discounted offering, casting doubt on the sustainability of HIMS's position in the weight-loss drug segment.
• The downward trend in HIMS stock price was intensified by general market conditions, as indicated by the negative sentiment affecting other companies like American Woodmark Corporation (AMWD) during the current trading session.

27.07.2024 - HIMS Stock was down 7.8%

• Hims & Hers Health stock dropped steeply due to the introduction of a lower-priced version of Eli Lilly's weight-loss drug, Zepbound. This move by Eli Lilly intensified concerns about competition and pricing for HIMS shares.
• The market's reaction to Eli Lilly's discounted Zepbound offering raised worries about Hims & Hers Health's competitiveness and growth potential in the telehealth and wellness sector.
• Investors were uncertain about HIMS' future due to the affordable weight-loss treatment option introduced by Eli Lilly, impacting the stock's performance.
• The negative market sentiment towards Hims & Hers Health was compounded by the general market trend and other companies like American Woodmark posting unfavorable results, adding to the downward pressure on HIMS stock.

06.08.2024 - HIMS Stock was down 5.2%

• Factors at a macro level have led to a significant drop in HIMS' stock price, despite its continuous efforts to improve its offerings and expand its range of products and services.
• Concerns among investors may arise regarding HIMS' capability to overcome these broader challenges while sustaining growth within the health and wellness industry.
• The stock has experienced a 32.1% decrease in value over the last three months, indicating a potential shift in market sentiment towards HIMS, likely influenced by general economic conditions impacting the company's future outlook.

08.07.2024 - HIMS Stock was down 5.1%

• The decline in HIMS stock might be linked to significant insider selling by the COO, chief legal officer, and CEO. This has raised concerns among investors about the company's future.
• Suggestions to "Buy The Dip" amidst the insider selling have generated mixed investor sentiments and increased selling pressure.
• Despite HIMS' substantial 52% growth in the second quarter, the impact of insider selling seems to have outweighed this positive news in today's trading.

07.07.2024 - HIMS Stock was down 7.3%

• Despite strong revenue growth and beating earnings estimates in Q2 2024, HIMS stock experienced a significant decline.
• The market may have reacted negatively due to concerns about the sustainability of the growth machine, despite the impressive 52% growth in the second quarter.
• Investors might be worried about the company's ability to maintain this growth trajectory, leading to a sell-off despite positive earnings results.
• The dip in HIMS stock could also be influenced by broader market trends or sector-specific challenges impacting telehealth companies.

07.07.2024 - HIMS Stock was down 5.8%

• Despite displaying robust revenue growth and surpassing earnings and revenue projections for Q2 2024, HIMS stock encountered notable bearish activity.
• The reaction of the market could be linked to concerns regarding future growth potential or the guidance given during the earnings call.
• Investors may be considering additional factors besides revenue and earnings, such as subscriber expansion and market competition, influencing the negative investor sentiment.
• The decline in the stock could have been influenced by profit-taking or market fluctuations unrelated to the company's performance, underscoring the unpredictable nature of stock shifts.

09.07.2024 - HIMS Stock was up 5.1%

• Deep-pocketed investors are adopting a bullish approach towards Hims & Hers Health, signaling confidence in the company's future prospects.
• The significant insider selling by the COO, chief legal officer, and CEO might have initially raised concerns, but the overall market sentiment remained positive, possibly due to strong fundamentals and growth potential of the company.
• The positive options trading trends and the overall market optimism surrounding HIMS could have outweighed the insider selling news, leading to the bullish movement in the stock today.

05.07.2024 - HIMS Stock was up 8.4%

• HIMS stock has gained 45.8% in the last three months, driven by the company's efforts to enhance its offerings and expand its product range in the health and wellness sector.
• The stock's surge may also be attributed to investors taking a bullish stance, as indicated by the increased options activity, possibly reflecting confidence in the company's future performance.
• Despite the positive momentum, there are concerns about macro challenges that could potentially impact HIMS' performance, indicating a need for caution despite the recent bullish movement.
• The company's controversial strategy to capitalize on the GLP-1 hype could be a double-edged sword, potentially fueling further growth but also raising questions about the stock's valuation and sustainability of its current rally.